{
    "startDate": "2020-01-01",
    "endDate": "2020-03-31",
    "year": "2020",
    "quarter": "Q1",
    "symbol": "APVO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 12258000
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 1343000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 1224000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 14825000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 2529000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3629000
            },
            {
                "label": "Operating lease right-of-use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 3504000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 757000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 25244000
            },
            {
                "label": "Accounts payable and other accrued liabilities",
                "concept": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 5001000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1085000
            },
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 907000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 6993000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 3099000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10092000
            },
            {
                "label": "Preferred stock: $0.001 par value; 15,000,000 shares authorized, zero shares issued or outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock: $0.001 par value; 500,000,000 shares authorized; 3,232,811 and 3,234,232 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 45000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 180066000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -164959000
            },
            {
                "label": "Stockholders' equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 15152000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 25244000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 2897000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 413000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 455000
            },
            {
                "label": "Gain on sale of Aptevo BioTherapeutics",
                "concept": "GainLossOnSaleOfBusiness",
                "unit": "usd",
                "value": 14338000
            },
            {
                "label": "Loss on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -2104000
            },
            {
                "label": "Non-cash interest expense and other.",
                "concept": "apvo:NonCashInterestExpenseAndOther",
                "unit": "usd",
                "value": 137000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 1329000
            },
            {
                "label": "Increase decrease in operating lease right of use assets.",
                "concept": "apvo:IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
                "unit": "usd",
                "value": 243000
            },
            {
                "label": "Accounts payable, accrued compensation and other liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -3248000
            },
            {
                "label": "Increase decrease in long term operating lease liability.",
                "concept": "apvo:IncreaseDecreaseInLongTermOperatingLeaseLiability",
                "unit": "usd",
                "value": 228000
            },
            {
                "label": "Increase decrease in assets and liabilities held for sale.",
                "concept": "apvo:IncreaseDecreaseInAssetsAndLiabilitiesHeldForSale",
                "unit": "usd",
                "value": -1719000
            },
            {
                "label": "Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -11175000
            },
            {
                "label": "Cash received from sale of Aptevo BioTherapeutics",
                "concept": "ProceedsFromDivestitureOfBusinesses",
                "unit": "usd",
                "value": 28120000
            },
            {
                "label": "Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 28120000
            },
            {
                "label": "Payments of long-term debt, including exit and other fees",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 22104000
            },
            {
                "label": "Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -22104000
            },
            {
                "label": "Increase (decrease) in cash, cash equivalents, and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -5159000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 4006000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 3616000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 7622000
            },
            {
                "label": "Other expense:",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -275000
            },
            {
                "label": "Loss on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -2104000
            },
            {
                "label": "Net loss from continuing operations",
                "concept": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -10001000
            },
            {
                "label": "Discontinued operations (Note 2):",
                "concept": "IncomeLossFromDiscontinuedOperationsNetOfTax",
                "unit": "usd",
                "value": 12898000
            },
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 2897000
            },
            {
                "label": "Net loss from continuing operations",
                "concept": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
                "unit": "usd/shares",
                "value": -3.06
            },
            {
                "label": "Net income (loss) from discontinued operations",
                "concept": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare",
                "unit": "usd/shares",
                "value": 3.94
            },
            {
                "label": "Basic and diluted net income (loss) per basic share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": 0.89
            },
            {
                "label": "Weighted-average shares used to compute per share calculations",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 3270089
            }
        ]
    }
}